The eye in hypertension

被引:489
作者
Wong, Tien
Mitchell, Paul
机构
[1] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia
[2] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore Eye Res Inst, Singapore 117548, Singapore
[3] Univ Sydney, Ctr Vis Res, Sydney, NSW 2006, Australia
基金
美国国家卫生研究院;
关键词
D O I
10.1016/S0140-6736(07)60198-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertension has a range of effects on the eye. Hypertensive retinopathy refers to retinal microvascular signs that develop in response to raised blood pressure. Signs of hypertensive retinopathy are frequently seen in adults 40 years and older, and are predictive of incident stroke, congestive heart failure, and cardiovascular mortality-independently of traditional risk factors. Hypertension is also a major risk factor for the development of other retinal vascular diseases, such as retinal vein and artery occlusion, and ischaemic optic neuropathy. High blood pressure increases the risk of both development of diabetic retinopathy and its progression. Adequate control of blood pressure has been proven in randomised clinical trials to reduce vision loss associated with diabetic retinopathy. Finally, hypertension has been implicated in the pathogenesis of glaucoma and age-related macular degeneration. Recognition of the ocular effects of blood pressure could allow physicians to better manage patients with hypertension, and to monitor its end-organ effects.
引用
收藏
页码:425 / 435
页数:11
相关论文
共 152 条
[1]   Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].
Adler, AI ;
Stratton, IM ;
Neil, HAW ;
Yudkin, JS ;
Matthews, DR ;
Cull, CA ;
Wright, AD ;
Turner, RC ;
Holman, RR .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419
[2]  
[Anonymous], 1986, Arch Ophthalmol, V104, P34
[3]  
[Anonymous], 1984, AM J OPHTHALMOL, V98, P271
[4]   Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion [J].
Arnold, M ;
Koerner, U ;
Remonda, L ;
Nedeltchev, K ;
Mattle, HP ;
Schroth, G ;
Sturzenegger, M ;
Weber, J ;
Koerner, F .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (02) :196-199
[5]   Efficacy of anterior chamber paracentesis and carbogen in treating acute nonarteritic central retinal artery occlusion [J].
Atebara, NH ;
Brown, GC ;
Cater, J .
OPHTHALMOLOGY, 1995, 102 (12) :2029-2034
[6]  
BOCK KD, 1984, HYPERTENSION, V6, P158
[7]   Vascular risk factors for primary open angle glaucoma -: The Egna-Neumarkt study [J].
Bonomi, L ;
Marchini, G ;
Marraffa, M ;
Bernardi, P ;
Morbio, R ;
Varotto, A .
OPHTHALMOLOGY, 2000, 107 (07) :1287-1293
[8]   RETINAL ARTERIOLAR MACROANEURYSMS - LONG-TERM VISUAL OUTCOME [J].
BROWN, DM ;
SOBOL, WM ;
FOLK, JC ;
WEINGEIST, TA .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1994, 78 (07) :534-538
[9]   VASCULAR OUTCOME IN MEN WITH ASYMPTOMATIC RETINAL CHOLESTEROL EMBOLI - A COHORT STUDY [J].
BRUNO, A ;
JONES, WL ;
AUSTIN, JK ;
CARTER, S ;
QUALLS, C .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (04) :249-253
[10]   CONCOMITANTS OF ASYMPTOMATIC RETINAL CHOLESTEROL EMBOLI [J].
BRUNO, A ;
RUSSELL, PW ;
JONES, WL ;
AUSTIN, JK ;
WEINSTEIN, ES ;
STEEL, SR .
STROKE, 1992, 23 (06) :900-902